Barclays Downgrades Acadia Healthcare (NASDAQ:ACHC) to Equal Weight

Acadia Healthcare (NASDAQ:ACHC) was downgraded by Barclays from an “overweight” rating to an “equal weight” rating in a report issued on Friday,Finviz reports. They presently have a $35.00 price target on the stock, down from their prior price target of $43.00. Barclays‘s price target points to a potential downside of 13.07% from the stock’s current price.

ACHC has been the subject of a number of other reports. Cantor Fitzgerald restated a “neutral” rating and set a $52.00 price objective on shares of Acadia Healthcare in a report on Tuesday, December 10th. KeyCorp upgraded Acadia Healthcare from a “sector weight” rating to an “overweight” rating and set a $70.00 price target for the company in a research note on Tuesday, January 7th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $64.00 price objective on shares of Acadia Healthcare in a research note on Friday, January 10th. StockNews.com cut Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Monday, January 6th. Finally, Deutsche Bank Aktiengesellschaft upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating and raised their price target for the company from $45.00 to $75.00 in a report on Thursday, December 12th. One analyst has rated the stock with a sell rating, three have issued a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat, Acadia Healthcare presently has an average rating of “Moderate Buy” and an average target price of $64.28.

Acadia Healthcare Stock Performance

NASDAQ:ACHC opened at $40.26 on Friday. Acadia Healthcare has a 1-year low of $36.50 and a 1-year high of $86.67. The firm has a 50 day simple moving average of $42.26 and a 200-day simple moving average of $52.22. The firm has a market cap of $3.74 billion, a PE ratio of 13.20, a P/E/G ratio of 1.46 and a beta of 1.30. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07.

Hedge Funds Weigh In On Acadia Healthcare

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. FMR LLC boosted its stake in shares of Acadia Healthcare by 257.9% in the fourth quarter. FMR LLC now owns 6,230,631 shares of the company’s stock valued at $247,045,000 after purchasing an additional 4,489,681 shares during the period. Madison Avenue Partners LP acquired a new position in Acadia Healthcare in the 4th quarter worth $76,339,000. Sachem Head Capital Management LP acquired a new position in Acadia Healthcare in the 4th quarter worth $52,734,000. Wellington Management Group LLP boosted its position in Acadia Healthcare by 12.2% in the 3rd quarter. Wellington Management Group LLP now owns 11,658,253 shares of the company’s stock valued at $739,250,000 after buying an additional 1,266,384 shares during the last quarter. Finally, Khrom Capital Management LLC acquired a new stake in shares of Acadia Healthcare during the fourth quarter valued at about $49,602,000.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.